| 01:28p | Pfizer-BioNTech COVID-19 Vaccine Booster Approved for Children 5 to 11 Years Old in US | MT |
| 12:18p | INSIDER SELL : Pfizer | MT |
| 11:50a | Pfizer, BioNTech Receive US Approval for COVID-19 Jab Booster Dose for Children | MT |
| 11:12a | Pfizer Gets FDA Emergency Use Authorization for COVID-19 Vaccine as Booster Dose in Chi.. | MT |
| 09:29a | AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Add Recommendation | MT |
| 08:55a | FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11 | DJ |
| 08:54a | Citigroup Adjusts Price Target on Johnson & Johnson to $205 From $210, Reiterates Buy R.. | MT |
| 08:49a | PRESS RELEASE : Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech.. | DJ |
| 08:41a | PFIZER INC : Barclays remains Neutral | MD |
| 05/16 | Mirati Therapeutics Appoints Laurie Stelzer CFO | MT |
| 05/16 | Berkshire Hathaway Exited Bristol Myers and AbbVie Stakes in 1Q | DJ |
| 05/16 | Eli Lilly Says FDA Approves Mounjaro Injection to Control Diabetes; Shares Rise | MT |
| 05/16 | GLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford... | |
| 05/16 | AbbVie Receives Option to License Worldwide Rights to Cugene's CUG252 for Autoimmune, I.. | MT |
| 05/16 | TRANSCRIPT : Roche Holding AG - Special Call | CI |
| 05/16 | INSIDER SELL : Pfizer | MT |
| 05/15 | Pfizer, BioNTech Agree To Move Delivery Schedules For COVID-19 Vaccines In EU | MT |
| 05/13 | FDA Approves Lilly's Mounjaro (Tirzepatide) Injection, the First and Only GIP and GLP-1.. | CI |
| 05/13 | FDA Approves Eli Lilly's Novel, Dual-Targeted Treatment for Type 2 Diabetes | MT |
| 05/13 | Berenberg Bank Adjusts Eli Lilly's Price Target to $345 From $305, Maintains Buy Rating | MT |
| 05/13 | N.Korea gets offers of aid to fight COVID as it lacks vaccines | RE |
| 05/13 | ROCHE HOLDINGS AG : Reduced to Neutral by Jefferies | MD |
| 05/12 | Roche believes cancer drug setback not a fatal blow to growth prospects | RE |
| 05/12 | ROCHE HOLDINGS AG : Gets a Neutral rating from Morgan Stanley | MD |
| 05/12 | ROCHE HOLDINGS AG : Deutsche Bank lowers his opinion and switches to Neutral | MD |
| 05/12 | Roche Teams Up With Global Fund To Boost Diagnostic Systems In Low, Middle-income Natio.. | MT |
| 05/11 | Declaration of Voting Results by AbbVie Inc | CI |
| 05/11 | Declaration of Voting Results by AbbVie Inc | CI |
| 05/11 | Declaration of Voting Results by AbbVie Inc | CI |
| 05/11 | Declaration of Voting Results by AbbVie Inc | CI |
| 05/11 | TRANSCRIPT : Johnson & Johnson Presents at Bank of America 2022 Healthcare Conference, May.. | CI |
| 05/11 | New class of cancer drugs down, not out, after Roche trial setback - analysts | RE |
| 05/11 | Pfizer's $11.6 billion Biohaven buy could spark more biotech deals | RE |
| 05/11 | Pfizer's South Africa COVID-19 Jab Production Plans Faces Scaleback As Demand Thins Out | MT |
| 05/11 | AbbVie Says Its Crohn's Disease Therapy Performed 'Significantly' Better Than Placebo i.. | MT |
| 05/11 | Roche, Electronic Health Solutions Team-Up on Healthcare Tech in Jordan | MT |
| 05/11 | Deutsche Bank Lowers Price Target on Roche, Downgrades Recommendation to Hold From Buy | MT |
| 05/11 | ROCHE HOLDINGS AG : Receives a Buy rating from Bernstein | MD |
| 05/11 | ROCHE HOLDINGS AG : Goldman Sachs gives a Buy rating | MD |
| 05/11 | Correction to AbbVie Upadacitinib Story | DJ |
| 05/11 | AbbVie Inc. Achieved Clinical Remission and Endoscopic Response At One Year in Phase 3 .. | CI |
| 05/11 | ROCHE HOLDINGS AG : Barclays reiterates its Buy rating | MD |
| 05/11 | ROCHE HOLDINGS AG : JP Morgan gives a Neutral rating | MD |
| 05/11 | Johnson & Johnson Names Thibaut Mongon CEO Designate of Planned New Consumer Health Com.. | MT |
| 05/11 | Eli Lilly and Incyte Say Olumiant, Their COVID-19 Treatment for Hospitalized Adults, Ap.. | MT |
| 05/11 | Johnson & Johnson Appoints CEO For Future Spin-off Unit | MT |
| 05/11 | ROCHE HOLDINGS AG : UBS reaffirms its Sell rating | MD |
| 05/11 | ABBVIE : Upadacitinib Achieved Clinical Remission at One Year in Crohn's Disease | DJ |
| 05/11 | Johnson & Johnson Announces Management Appointments for Planned New Consumer Health Com.. | CI |
| 05/11 | FDA Approves Lilly, Incyte Drug Olumiant for Certain Hospitalized Covid Patients | DJ |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
